APAF1
Gene Information
- Official Symbol: APAF1
- Official Name: apoptotic peptidase activating factor 1
- Aliases and Previous Symbols: N/A
- Entrez ID: 317
- UniProt: O14727
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes a cytoplasmic protein that initiates apoptosis. This protein contains several copies of the WD-40 domain, a caspase recruitment domain (CARD), and an ATPase domain (NB-ARC). Upon binding cytochrome c and dATP, this protein forms an oligomeric apoptosome. The apoptosome binds and cleaves caspase 9 preproprotein, releasing its mature, activated form. Activated caspase 9 stimulates the subsequent caspase cascade that commits the cell to apoptosis. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| WD40 |
| NB-ARC |
| CARD |
GO Terms
| response to G1 DNA damage checkpoint signaling |
| response to mitotic cell cycle checkpoint signaling |
| apoptosome |
| striated muscle cell apoptotic process |
| cardiac muscle cell apoptotic process |
| muscle cell apoptotic process |
| response to DNA damage checkpoint signaling |
| response to DNA integrity checkpoint signaling |
| response to cell cycle checkpoint signaling |
| activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
| regulation of apoptotic DNA fragmentation |
| regulation of DNA catabolic process |
| cysteine-type endopeptidase activator activity involved in apoptotic process |
| intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| ADP binding |
| negative regulation of G0 to G1 transition |
| regulation of execution phase of apoptosis |
| regulation of G0 to G1 transition |
| neuron apoptotic process |
| neuron death |
| heat shock protein binding |
| nucleotide binding |
| activation of cysteine-type endopeptidase activity involved in apoptotic process |
| neural tube closure |
| tube closure |
| primary neural tube formation |
| neural tube formation |
| secretory granule lumen |
| embryonic epithelial tube formation |
| ficolin-1-rich granule lumen |
| epithelial tube formation |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| morphogenesis of embryonic epithelium |
| tube formation |
| intrinsic apoptotic signaling pathway |
| positive regulation of cysteine-type endopeptidase activity |
| cellular response to transforming growth factor beta stimulus |
| neural tube development |
| response to transforming growth factor beta |
| positive regulation of endopeptidase activity |
| positive regulation of apoptotic signaling pathway |
| positive regulation of peptidase activity |
| cellular response to biotic stimulus |
| response to nutrient |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| regulation of cysteine-type endopeptidase activity |
| response to endoplasmic reticulum stress |
| kidney development |
| aging |
| renal system development |
| apoptotic signaling pathway |
| epithelial tube morphogenesis |
| urogenital system development |
| negative regulation of cell cycle process |
| protein homooligomerization |
| response to hypoxia |
| regulation of DNA metabolic process |
| positive regulation of proteolysis |
| response to decreased oxygen levels |
| response to oxygen levels |
| forebrain development |
| regulation of apoptotic signaling pathway |
| regulation of endopeptidase activity |
| morphogenesis of an epithelium |
| regulation of peptidase activity |
| neutrophil degranulation |
| neutrophil activation involved in immune response |
| neutrophil mediated immunity |
| response to nutrient levels |
| cellular response to growth factor stimulus |
| neutrophil activation |
| granulocyte activation |
| leukocyte degranulation |
| myeloid leukocyte mediated immunity |
| protein complex oligomerization |
| myeloid cell activation involved in immune response |
| response to extracellular stimulus |
| response to growth factor |
| tissue morphogenesis |
| embryonic morphogenesis |
| negative regulation of cell cycle |
| myeloid leukocyte activation |
| protein-containing complex |
| leukocyte activation involved in immune response |
| cell activation involved in immune response |
| chordate embryonic development |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| embryo development ending in birth or egg hatching |
| tube morphogenesis |
| positive regulation of cell death |
| regulated exocytosis |
| regulation of proteolysis |
| brain development |
| regulation of cell cycle process |
| leukocyte mediated immunity |
| positive regulation of hydrolase activity |
| head development |
| exocytosis |
| regulation of cellular catabolic process |
| tube development |
| anatomical structure formation involved in morphogenesis |
| apoptotic process |
| leukocyte activation |
| embryo development |
| central nervous system development |
| regulation of catabolic process |
| secretion by cell |
| export from cell |
| programmed cell death |
| identical protein binding |
| cell activation |
| cell death |
| immune effector process |
| epithelium development |
| secretion |
| response to abiotic stimulus |
| regulation of cell cycle |
| cellular response to endogenous stimulus |
| regulation of hydrolase activity |
| response to biotic stimulus |
| positive regulation of catalytic activity |
| response to endogenous stimulus |
| ATP binding |
| regulation of apoptotic process |
| protein-containing complex assembly |
| regulation of programmed cell death |
| positive regulation of cellular protein metabolic process |
| positive regulation of signal transduction |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| positive regulation of protein metabolic process |
| tissue development |
| positive regulation of molecular function |
| positive regulation of cell communication |
| positive regulation of signaling |
| protein-containing complex subunit organization |
| immune response |
| extracellular region |
| vesicle-mediated transport |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| BAK1 | 0.82 |
| CASP9 | 0.79 |
| VDAC2 | 0.756 |
| PLAA | 0.756 |
| MARCH5 | 0.744 |
| CYCS | 0.742 |
| UBQLN1 | 0.726 |
| HCCS | 0.722 |
| DIABLO | 0.691 |
| FAF2 | 0.653 |
| HARS | 0.635 |
| DOHH | 0.629 |
| HSPD1 | 0.619 |
| SERF2 | 0.602 |
| ENY2 | 0.584 |
| MFN1 | 0.576 |
| ATAD1 | 0.575 |
| BAP1 | 0.573 |
| TRIAP1 | 0.572 |
| ROMO1 | 0.561 |
| CRLS1 | 0.56 |
| THG1L | 0.556 |
| UAP1 | 0.554 |
| RPTOR | 0.547 |
| STAU1 | 0.539 |
| GABPA | 0.536 |
| GFPT1 | 0.535 |
| CSNK2B | 0.534 |
| PPP2R3C | 0.533 |
| METAP2 | 0.517 |
| MTOR | 0.517 |
| GMPPB | 0.516 |
| SRP14 | 0.51 |
| PPA2 | 0.507 |
| RAD23B | 0.505 |
| MEAF6 | 0.504 |
| UBE2K | 0.504 |
| PMM2 | 0.501 |
| TAZ | 0.498 |
| KDSR | 0.497 |
| DDHD2 | 0.493 |
| VHL | 0.487 |
| ATP5J | 0.486 |
| SEC61G | 0.481 |
| TAMM41 | 0.479 |
| PISD | 0.476 |
| RNMT | 0.474 |
| OPA1 | 0.473 |
| RTCB | 0.473 |
| MLST8 | 0.471 |
| UBE2G2 | 0.471 |
| DPAGT1 | 0.47 |
| NSD1 | 0.466 |
| CTDNEP1 | 0.465 |
| ATP2A2 | 0.463 |
| UBA3 | 0.462 |
| ATXN10 | 0.458 |
| NAE1 | 0.456 |
| ALG1 | 0.454 |
| PIK3R4 | 0.454 |
| GTF3A | 0.45 |
| ALG2 | 0.448 |
| CBFB | 0.448 |
| FECH | 0.447 |
| ABCF1 | 0.447 |
| RPN1 | 0.443 |
| PAM16 | 0.442 |
| TIMM13 | 0.441 |
| NXT1 | 0.44 |
| WDR59 | 0.439 |
| EIF3F | 0.439 |
| WDR24 | 0.438 |
| ATP5I | 0.437 |
| ZZZ3 | 0.436 |
| PDPK1 | 0.433 |
| ATP5O | 0.431 |
| ATP5A1 | 0.43 |
| NUPL2 | 0.43 |
| CEPT1 | 0.429 |
| GTF3C6 | 0.427 |
| BRWD1 | 0.427 |
| TP53 | 0.427 |
| DHPS | 0.424 |
| EXOC4 | 0.423 |
| GTF3C3 | 0.423 |
| SEC16A | 0.419 |
| ALG5 | 0.418 |
| TRIM28 | 0.416 |
| PPP5C | 0.415 |
| PELO | 0.414 |
| ATP5F1 | 0.413 |
| CARS | 0.412 |
| SLC25A26 | 0.411 |
| SLMO2 | 0.411 |
| DAD1 | 0.411 |
| TBCA | 0.41 |
| EIF4E | 0.409 |
| RBMX2 | 0.408 |
| SRRD | 0.407 |
| ATP5B | 0.407 |
| UBE2M | 0.406 |
| GNAS | 0.403 |
| KCTD5 | 0.402 |
| FBXO11 | 0.401 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 16386
- Expression level (log2 read counts): 5.79
Expression Distribution
APAF1 Expression in NALM6 Cells: 5.79